Stada Arzneimittel AG (SAZ):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Stada Arzneimittel AG (SAZ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7190
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of products in various therapeutic categories including pain, women’s health, cardiovascular conditions and diabetes. Few of its major generic products include including Tilidin Naloxon, Atorvastatin, Pantoprazol, Epoetin zeta and Diclofenac. Its major branded products include APO-Go, Grippostad, Snup, Fultium, and Vitaprost. The company operates in more than 30 countries with sales in Germany, Central Europe, CIS/Eastern Europe and Asia-Pacific. STADA is headquartered in Bad Vilbel, Germany.

Stada Arzneimittel AG (SAZ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stada Arzneimittel AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stada Arzneimittel AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Stada Arzneimittel AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stada Arzneimittel AG, Medical Equipment, Deal Details 10
Private Equity 10
Bain Capital and Cinven Partners to Acquire Stada Arzneimittel 10
Partnerships 12
3M Enters Into Licensing Agreement With Stada For Fentanyl Transdermal Patch Technology 12
Lophius Biosciences Enters into Agreement with BL&H 13
Vigilant Biosciences Enters into Distribution Agreement with BL&H 14
Acquisition 15
Nidda Healthcare to Acquire Stake in Stada Arzneimittel 15
STADA Arzneimittel Acquires SCIOTEC Diagnostic Technologies for USD19.8 Million 16
Stada Arzneimittel AG – Key Competitors 17
Stada Arzneimittel AG – Key Employees 18
Stada Arzneimittel AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 22
Financial Announcements 22
Aug 09, 2018: STADA’s business development in the first six months of 2018 as expected 22
May 03, 2018: STADA with solid business development in the first quarter of 2018 24
Mar 08, 2018: STADA records positive business development in 2017 26
Nov 09, 2017: STADA shows good business development in the third quarter of 2017 and the first nine months 29
Corporate Communications 31
Sep 03, 2018: Peter Goldschmidt to succeed Claudio Albrecht as STADA’s CEO 31
Apr 16, 2018: Changes in the management team of STADA 32
Feb 01, 2018: Supervisory Board of STADA Arzneimittel appoints Peter Goldschmidt as new Chairman of the Executive Board as of September 1, 2018 33
Feb 01, 2018: Peter Goldschmidt to succeed Claudio Albrecht as CEO on 1 September 2018 34
Jul 04, 2017: STADA Arzneimittel appoints new Chief Executive Officer and Chief Financial Officer – incumbents step down from their positions 35
Apr 24, 2017: Dr. Ralph Grobecker to become Managing Director of STADA’s OTC segment 36
Other Significant Developments 37
Sep 12, 2018: STADA invites the holders of the STADA Bond to participate in the bondholders meeting and to vote in favor of the proposed resolutions 37
Aug 03, 2017: STADA shows good operational development in first six months of 2017 38
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Stada Arzneimittel AG, Medical Equipment, Key Facts, 2017 2
Stada Arzneimittel AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stada Arzneimittel AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stada Arzneimittel AG, Deals By Market, 2012 to YTD 2018 8
Stada Arzneimittel AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bain Capital and Cinven Partners to Acquire Stada Arzneimittel 10
3M Enters Into Licensing Agreement With Stada For Fentanyl Transdermal Patch Technology 12
Lophius Biosciences Enters into Agreement with BL&H 13
Vigilant Biosciences Enters into Distribution Agreement with BL&H 14
Nidda Healthcare to Acquire Stake in Stada Arzneimittel 15
STADA Arzneimittel Acquires SCIOTEC Diagnostic Technologies for USD19.8 Million 16
Stada Arzneimittel AG, Key Competitors 17
Stada Arzneimittel AG, Key Employees 18
Stada Arzneimittel AG, Subsidiaries 19

List of Figures
Stada Arzneimittel AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stada Arzneimittel AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stada Arzneimittel AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Stada Arzneimittel AG (SAZ):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Breeze-Eastern Corporation:企業の戦略・SWOT・財務情報
    Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report Summary Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Oglethorpe Power Corporation:電力:M&Aディール及び事業提携情報
    Summary Oglethorpe Power Corporation (Oglethorpe) is a member-owned non-profit electric utility that provides wholesale electric power to retail electric distribution cooperative members. The cooperative operates through a diverse portfolio of owned and leased power supply resources utilizing natura …
  • Nihon Kohden Corporation:企業の戦略・SWOT・財務情報
    Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report Summary Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nanomix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nanomix Inc (Nanomix) is a medical device company that develops analytical detection devices for the point of care diagnostics. The company provides Nanomix system, which is an automated system consisting of a handheld reader and self-contained assay cartridge with a carbon nanotube biosenso …
  • Jaiprakash Power Ventures Ltd (JPPOWER):電力:M&Aディール及び事業提携情報
    Summary Jaiprakash Power Ventures Ltd (Jaiprakash Power) is a power utility. It plans, develops, implements, and operates electric projects. The company produces electricity using hydro and coal sources. Jaiprakash Power also has development interests in the Hirong hydroelectric project and the Lowe …
  • CivaTech Oncology Inc-医療機器分野:企業M&A・提携分析
    Summary CivaTech Oncology Inc (CivaTech) is a medical device company that provides radiation therapy solutions. The company develops polymer based low dose rate (LDR) brachytherapy devices for the treatment of cancer. Its product portfolio includes CivaString, a radiation therapy device to treat sol …
  • DiaSys Diagnostic Systems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary DiaSys Diagnostic Systems GmbH (DiaSys Diagnostic) is a developer, manufacturer and marketer of point of care diagnostic products. The company’s products include automated analyzers, calibrators or controls, POCT systems and tests, reagents, system kits and OEM products. It provides automate …
  • Acer Inc (2353):企業の財務・戦略的SWOT分析
    Acer Inc (2353) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • XL-protein GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary XL-protein GmbH (XL-protein) is a biopharmaceutical company that develops second generation biopharmaceutical drugs. The company develops PASylation technology, designed to enable the biopharmaceuticals drug development with extended plasma half-life and enhanced action. It provides its tech …
  • Warrnambool Cheese and Butter Factory Company Holdings Limited:企業の戦略・SWOT・財務情報
    Warrnambool Cheese and Butter Factory Company Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Warrnambool Cheese and Butter Factory Company Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report cov …
  • Safe Orthopaedics SA (SAFOR):企業の財務・戦略的SWOT分析
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • The Goldman Sachs Group Inc (GS):企業の財務・戦略的SWOT分析
    The Goldman Sachs Group Inc (GS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tokyo Seimitsu Co., Ltd. (7729):企業の財務・戦略的SWOT分析
    Tokyo Seimitsu Co., Ltd. (7729) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Zuger Kantonalbank AG:企業の戦略・SWOT・財務分析
    Zuger Kantonalbank AG - Strategy, SWOT and Corporate Finance Report Summary Zuger Kantonalbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Varian Medical Systems, Inc.:企業の戦略・SWOT・財務情報
    Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Micro Focus International Plc (MCRO):企業の財務・戦略的SWOT分析
    Micro Focus International Plc (MCRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Israel Electric Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary The Israel Electric Corporation Ltd (IECL), formerly Palestine Electric Corporation Ltd. is an integrated electric utility that carries out the generation, transmission, distribution, sale and supply of electricity. The State of Israel owns around 99.85% of the company. It generates power ma …
  • Infinity Pharmaceuticals Inc (INFI):企業の財務・戦略的SWOT分析
    Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sangam (India) Ltd.:企業の戦略・SWOT・財務分析
    Sangam (India) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sangam (India) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • American Airlines Group Inc (AAL):企業の財務・戦略的SWOT分析
    American Airlines Group Inc (AAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆